Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)

Odds Ratios for Mediation Analysis for a Dichotomous Outcome

(2010) T. J. VanderWeele et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Naturally Occurring Variants of Human Aldo-Keto Reductases with Reduced In Vitro Metabolism of Daunorubicin and Doxorubicin

(2010) O. S. Bains et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers

(2009) J.-M. Yuan et al.   CANCER RESEARCH

Effects of Smoking Cessation on Eight Urinary Tobacco Carcinogen and Toxicant Biomarkers

(2009) Steven G. Carmella et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Functional Effects of Polymorphisms in the Human Gene Encoding 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1): A Sequence Variant at the Translation Start of 11β-HSD1 Alters Enzyme Levels

(2009) Elise L. V. Malavasi et al.   ENDOCRINOLOGY

Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine

(2009) Dominique Kavvadias et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Extensive Metabolic Activation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Smokers

(2008) I. Stepanov et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines

(2008) Gang Chen et al.   Pharmacogenetics and Genomics

CYP2A6polymorphisms and risk for tobacco-related cancers

(2008) Ana Rossini et al.   PHARMACOGENOMICS

Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis

(2008) Richard D. Egleton et al.   TRENDS IN PHARMACOLOGICAL SCIENCES